PTCT · PTC Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Michael Schmertzler Director | ▼ Sell | Open Market | 1,294,094 Shares held | 10/7/2026 | View profile |
| Matthew B. Klein Director | ▼ Sell | Open Market | 383,868 Shares held | 8/4/2026 | View profile |
| Mark Elliott Boulding EXEC. VP AND CLO | ▼ Sell | Open Market | 105,272 Shares held | 10/6/2026 | View profile |
| Pierre Gravier CHIEF FINANCIAL OFFICER | ▼ Sell | Open Market | 83,986 Shares held | 7/14/2026 | View profile |
| Lee Scott Golden CHIEF MEDICAL OFFICER | ▼ Sell | Open Market | 79,115 Shares held | 4/2/2026 | View profile |
| Eric Pauwels Chief Business Officer | ▼ Sell | Open Market | 73,411 Shares held | 6/10/2026 | View profile |
| Christine Marie Utter SVP, Finance & CAO | ▼ Sell | Open Market | 70,199 Shares held | 6/17/2026 | View profile |
| Neil Gregory Almstead Chief Technical Ops Officer | ▼ Sell | Open Market | 60,299 Shares held | 7/9/2026 | View profile |
| Peltz Stuart Walter Chief Executive Officer | ▼ Sell | Open Market | 54,903 Shares held | 1/31/2023 | View profile |
| Hege Elisabeth Sollie-Zetlmayer | ▲ Buy | Grant | 52,526 Shares held | 7/28/2026 | View profile |
| Hill Emily Luisa Chief Financial Officer | ▼ Sell | Open Market | 38,925 Shares held | 3/27/2023 | View profile |
| Svoronos Dawn Director | ▼ Sell | Open Market | 29,017 Shares held | 6/9/2022 | View profile |
| Jerome B. Zeldis Director | ▲ Buy | Grant | 22,500 Shares held | 1/2/2026 | View profile |
| STEELE GLENN JR MD PHD Director | ▼ Sell | Open Market | 22,500 Shares held | 9/30/2026 | View profile |
| Mary L. Smith Director | ▼ Sell | Open Market | 21,813 Shares held | 7/9/2026 | View profile |
| Jacobson Allan Steven Director | ▲ Buy | Grant | 21,451 Shares held | 1/2/2026 | View profile |
| Alethia Young Director | ▲ Buy | Grant | 21,067 Shares held | 1/2/2026 | View profile |
| David P. Southwell Chief Executive Officer | ▲ Buy | Grant | 20,850 Shares held | 1/2/2026 | View profile |
| Reeve Emma Director | ▼ Sell | Open Market | 10,666 Shares held | 1/5/2026 | View profile |
| Bell William F. Jr. | ▲ Buy | Grant | 10,333 Shares held | 2/15/2024 | View profile |
| Stephanie Okey Director | ▼ Sell | Open Market | 8,000 Shares held | 3/10/2026 | View profile |
| Jessica Caroline Chutter | ▲ Buy | Grant | 7,333 Shares held | 3/24/2026 | View profile |
Transaction History
| Michael Schmertzler | ▼ Sell | Open Market | 2,447 | $155K | 10/7/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 53 | $3K | 10/7/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 435 | $17K | 10/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 435 | $28K | 10/6/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 1,638 | $65K | 10/5/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,638 | $105K | 10/5/2026 |
| STEELE GLENN JR MD PHD | ▲ Buy | Option Exercise | 12,000 | $135K | 9/30/2026 |
| STEELE GLENN JR MD PHD | ▼ Sell | Open Market | 12,000 | $782K | 9/30/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 9,624 | $653K | 9/17/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 376 | $26K | 9/17/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 2,994 | $199K | 9/16/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 7,006 | $472K | 9/16/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 10,000 | $673K | 9/10/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 572 | $39K | 9/9/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 9,428 | $639K | 9/9/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 11,890 | $851K | 8/27/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 610 | $44K | 8/27/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 6,874 | $500K | 8/26/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 5,626 | $412K | 8/26/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 9,419 | $667K | 8/20/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 2,390 | $172K | 8/20/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 691 | $50K | 8/20/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 5,335 | $389K | 8/19/2026 |
| Michael Schmertzler | ▼ Sell | Open Market | 7,165 | $528K | 8/19/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,813 | $72K | 8/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,844 | $133K | 8/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 969 | $71K | 8/17/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 10,292 | $706K | 8/4/2026 |
| Hege Elisabeth Sollie-Zetlmayer | ▲ Buy | Grant | 4,000 | $0 | 7/28/2026 |
| Hege Elisabeth Sollie-Zetlmayer | ▲ Buy | Grant | 2,000 | $0 | 7/28/2026 |
| Pierre Gravier | ▼ Sell | Open Market | 3,494 | $281K | 7/14/2026 |
| Mary L. Smith | ▲ Buy | Option Exercise | 10,000 | $430K | 7/9/2026 |
| Mary L. Smith | ▼ Sell | Open Market | 10,000 | $900K | 7/9/2026 |
| Mary L. Smith | ▲ Buy | Option Exercise | 5,834 | $251K | 7/9/2026 |
| Mary L. Smith | ▼ Sell | Open Market | 5,834 | $525K | 7/9/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 2,464 | $115K | 7/9/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 2,464 | $222K | 7/9/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 11,369 | $1.0M | 7/7/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 9,288 | $831K | 7/7/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 24,613 | $970K | 7/7/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 3,956 | $345K | 7/7/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,266 | $89K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 313 | $26K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 833 | $70K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 519 | $45K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 601 | $52K | 7/6/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,813 | $131K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 387 | $32K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,036 | $87K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 645 | $55K | 7/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 745 | $64K | 7/6/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 811 | $31K | 7/6/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 426 | $36K | 7/6/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 385 | $33K | 7/6/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 18,876 | $719K | 7/6/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 8,786 | $750K | 7/6/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 10,090 | $871K | 7/6/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 2,474 | $98K | 7/6/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 2,474 | $215K | 7/6/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 412 | $16K | 6/26/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 412 | $35K | 6/26/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 7,718 | $294K | 6/26/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 7,718 | $658K | 6/26/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 11,337 | $981K | 6/25/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 100 | $4K | 6/25/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 100 | $9K | 6/25/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 1,001 | $38K | 6/25/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 582 | $50K | 6/25/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 19,859 | $757K | 6/25/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 8,522 | $727K | 6/25/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 419 | $36K | 6/25/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 401 | $15K | 6/24/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 401 | $34K | 6/24/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 4,922 | $188K | 6/24/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 4,922 | $419K | 6/24/2026 |
| Neil Gregory Almstead | ▲ Buy | Option Exercise | 23,749 | $610K | 6/22/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 12,130 | $978K | 6/22/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 11,619 | $944K | 6/22/2026 |
| Christine Marie Utter | ▲ Buy | Option Exercise | 19,686 | $506K | 6/17/2026 |
| Christine Marie Utter | ▼ Sell | Open Market | 19,686 | $1.5M | 6/17/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 8,510 | $396K | 6/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 6,600 | $518K | 6/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,850 | $147K | 6/17/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,012 | $94K | 6/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,703 | $134K | 6/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 309 | $24K | 6/17/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 3,711 | $278K | 6/10/2026 |
| Eric Pauwels | ▲ Buy | Option Exercise | 17,566 | $316K | 6/10/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 17,566 | $1.3M | 6/10/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,812 | $72K | 5/15/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 2,356 | $170K | 5/15/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 456 | $33K | 5/15/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 679 | $50K | 5/14/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 7,221 | $528K | 5/14/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 2,100 | $153K | 5/14/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 2,572 | $186K | 5/14/2026 |
| Matthew B. Klein | ▲ Buy | Grant | 12,500 | $0 | 5/13/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,740 | $128K | 5/8/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 840 | $66K | 5/8/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,900 | $151K | 5/8/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 800 | $37K | 5/8/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 200 | $16K | 5/8/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 600 | $48K | 5/8/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 2,850 | $202K | 4/21/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,265 | $89K | 4/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 822 | $57K | 4/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,443 | $101K | 4/6/2026 |
| Lee Scott Golden | ▼ Sell | Open Market | 829 | $56K | 4/2/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 39,393 | $2.7M | 4/1/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 12,530 | $871K | 4/1/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 80 | $6K | 4/1/2026 |
| Jessica Caroline Chutter | ▲ Buy | Grant | 4,000 | $0 | 3/24/2026 |
| Jessica Caroline Chutter | ▲ Buy | Grant | 3,333 | $0 | 3/24/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 2,662 | $171K | 3/12/2026 |
| Matthew B. Klein | ▲ Buy | Grant | 12,500 | $0 | 3/11/2026 |
| Stephanie Okey | ▲ Buy | Option Exercise | 1,167 | $39K | 3/10/2026 |
| Stephanie Okey | ▼ Sell | Open Market | 14,000 | $980K | 3/10/2026 |
| Stephanie Okey | ▼ Sell | Open Market | 1,167 | $82K | 3/10/2026 |
| Stephanie Okey | ▲ Buy | Option Exercise | 14,000 | $471K | 3/10/2026 |
| Stephanie Okey | ▼ Sell | Open Market | 6,333 | $401K | 3/5/2026 |
| Lee Scott Golden | ▼ Sell | Open Market | 10,000 | $634K | 3/5/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 3,989 | $253K | 3/5/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 588 | $40K | 2/19/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,629 | $114K | 2/19/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 590 | $41K | 2/19/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 212 | $15K | 2/19/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 7,371 | $511K | 2/18/2026 |
| Lee Scott Golden | ▼ Sell | Open Market | 2,484 | $172K | 2/18/2026 |
| Pierre Gravier | ▼ Sell | Open Market | 2,992 | $208K | 2/18/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 3,019 | $209K | 2/18/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 3,056 | $212K | 2/18/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 65 | $5K | 2/18/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 3,081 | $214K | 2/18/2026 |
| Christine Marie Utter | ▼ Sell | Open Market | 2,494 | $173K | 2/18/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,813 | $72K | 2/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 2,811 | $195K | 2/17/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 2 | $140 | 2/17/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 1,024 | $81K | 1/12/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 1,722 | $133K | 1/9/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,521 | $118K | 1/9/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 686 | $54K | 1/9/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 107 | $9K | 1/9/2026 |
| Christine Marie Utter | ▼ Sell | Open Market | 1,034 | $79K | 1/8/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 2,561 | $196K | 1/8/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 587 | $45K | 1/8/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 1,454 | $111K | 1/8/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 2,514 | $192K | 1/8/2026 |
| Lee Scott Golden | ▼ Sell | Open Market | 866 | $66K | 1/8/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 2,482 | $190K | 1/8/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 265 | $20K | 1/8/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,286 | $98K | 1/8/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 881 | $67K | 1/8/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 59 | $5K | 1/8/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 3,016 | $234K | 1/7/2026 |
| Christine Marie Utter | ▼ Sell | Open Market | 1,235 | $96K | 1/7/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 1,352 | $105K | 1/7/2026 |
| Lee Scott Golden | ▼ Sell | Open Market | 642 | $50K | 1/7/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,503 | $116K | 1/7/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,625 | $100K | 1/7/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,638 | $126K | 1/7/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 949 | $74K | 1/7/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 38 | $3K | 1/7/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 751 | $29K | 1/7/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 471 | $36K | 1/7/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 269 | $21K | 1/7/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 11 | $869 | 1/7/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 1,026 | $79K | 1/7/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 52 | $4K | 1/7/2026 |
| Lee Scott Golden | ▼ Sell | Open Market | 1,340 | $103K | 1/6/2026 |
| Christine Marie Utter | ▼ Sell | Open Market | 1,381 | $106K | 1/6/2026 |
| Pierre Gravier | ▼ Sell | Open Market | 2,139 | $165K | 1/6/2026 |
| Eric Pauwels | ▼ Sell | Open Market | 1,789 | $138K | 1/6/2026 |
| Matthew B. Klein | ▼ Sell | Open Market | 5,149 | $396K | 1/6/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,739 | $134K | 1/6/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 1,279 | $98K | 1/6/2026 |
| Neil Gregory Almstead | ▼ Sell | Open Market | 54 | $4K | 1/6/2026 |
| Mark Elliott Boulding | ▲ Buy | Option Exercise | 2,266 | $89K | 1/5/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,123 | $84K | 1/5/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 1,035 | $79K | 1/5/2026 |
| Mark Elliott Boulding | ▼ Sell | Open Market | 108 | $8K | 1/5/2026 |
| Reeve Emma | ▲ Buy | Option Exercise | 734 | $34K | 1/5/2026 |
| Reeve Emma | ▼ Sell | Open Market | 734 | $56K | 1/5/2026 |
| Mark Elliott Boulding | ▲ Buy | Grant | 17,000 | $0 | 1/2/2026 |
| Reeve Emma | ▲ Buy | Grant | 4,000 | $0 | 1/2/2026 |
| Mary L. Smith | ▲ Buy | Grant | 4,000 | $0 | 1/2/2026 |
| Neil Gregory Almstead | ▲ Buy | Grant | 17,500 | $0 | 1/2/2026 |
| Neil Gregory Almstead | ▲ Buy | Grant | 520 | $0 | 1/2/2026 |
| Christine Marie Utter | ▲ Buy | Grant | 13,250 | $0 | 1/2/2026 |
| Lee Scott Golden | ▲ Buy | Grant | 18,750 | $0 | 1/2/2026 |
| Eric Pauwels | ▲ Buy | Grant | 20,000 | $0 | 1/2/2026 |
| Jerome B. Zeldis | ▲ Buy | Grant | 4,000 | $0 | 1/2/2026 |
| Alethia Young | ▲ Buy | Grant | 4,000 | $0 | 1/2/2026 |
| David P. Southwell | ▲ Buy | Grant | 4,000 | $0 | 1/2/2026 |
| Stephanie Okey | ▲ Buy | Grant | 4,000 | $0 | 1/2/2026 |
| Jacobson Allan Steven | ▲ Buy | Grant | 4,000 | $0 | 1/2/2026 |
| Michael Schmertzler | ▲ Buy | Grant | 8,000 | $0 | 1/2/2026 |
| Pierre Gravier | ▲ Buy | Grant | 20,000 | $0 | 1/2/2026 |
| Matthew B. Klein | ▲ Buy | Grant | 63,000 | $0 | 1/2/2026 |
| STEELE GLENN JR MD PHD | ▲ Buy | Option Exercise | 12,000 | $370K | 1/2/2026 |
| STEELE GLENN JR MD PHD | ▼ Sell | Open Market | 12,000 | $916K | 1/2/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
PTC Therapeutics to Report Q3 2026 Earnings on Oct 29
PTC Therapeutics has announced it will release its third-quarter 2026 financial results on October 29, 2026. This upcoming report is the primary catalyst for the stock in the near term. The company's shares are currently trading below the average analyst price target, with the stock recently testing key support levels.
PTC Therapeutics to Report Q3 2026 Earnings on Oct 29. PTC Therapeutics has announced it will release its third-quarter 2026 financial results on October 29, 2026. This upcoming report is the primary catalyst for the stock in the near term. The company's shares are currently trading below the average analyst price target, with the stock recently testing key support levels.